Matsubara N, de Wit R, Balar AV, Siefker-Radtke AO, et al. Pembrolizumab with or Without Lenvatinib as First-line Therapy for Patients with Advanced Urothelial Carcinoma (LEAP-011): A Phase 3, Randomized, Double-Blind Trial. Eur Urol 2024;85:229-238.
PMID: 37778952